- This topic has 3 replies, 3 voices, and was last updated 1 year, 5 months ago by
.
-
Posts
-
-
“The phases of clinical research are the stages in which scientists conduct experiments with a health intervention to obtain sufficient evidence for a process considered effective as a medical treatment.[1] For drug development, the clinical phases start with testing for safety in a few human subjects, then expand to many study participants (potentially tens of thousands) to determine if the treatment is effective.[1] Clinical research is conducted on drug candidates, vaccine candidates, new medical devices, and new diagnostic assays.”
https://en.wikipedia.org/wiki/Phases_of_clinical_research
Understanding the phases of clinical research
-
These phases don’t even mention the phase of timing releases of information to investors. I believe phases are timed to maximize investors increasing the stock price of these development companies. A fast trial and weak results not too great for bottom line.
-
-
Interestingly the trial I’m about to start is a Phase 1b/2a first-in-human trial. Progress & dosing regimen in Phase 2b is dependent on safety & efficacy results from Phase 1b. Some participants will skip Phase 1b.
For better or worse, as the first participant I’m a sentinel. I have more intensive monitoring, but also a greater chance of placebo. Why?????
-
- You must be logged in to reply to this topic.
